Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ETOPOSIDE, with a corresponding US DMF Number 41308.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 04, 2025, and payment made on February 25, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II